Rockwell Medical Determines Medical Resource Acquisition Group's Director Nominations Are Invalid
March 11, 2020 at 06:00 pm IST
Share
On March 11, 2020, Rockwell Medical, Inc. announced that its board of directors has determined that Medical Resource Acquisition Group LLC (MRAG) failed to properly deliver a notice of director nominations under the Company's Bylaws within the prescribed advance notice period. As such, its 3 director nominees will not stand for election at the 2020 annual meeting of stockholders.
Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers around the world. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. It is the supplier of life-sustaining hemodialysis concentrates products to dialysis clinics. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patientâs bloodstream. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.